14-day Premium Trial Subscription Sign Up For FreeGet Free

Windtree Therapeutics Inc Stock Forecast NASDAQ:WINT

$1.18 (2.61%)

Volume: 56k

Closed: Jan 25, 2022

Hollow Logo Score: -5.847

Windtree Therapeutics Inc Stock Forecast

$1.18 (2.61%)

Volume: 56k

Closed: Jan 25, 2022

Score Hollow Logo -5.847

Windtree Therapeutics Inc Company Profile

2600 Kelly Road

Warrington PA 18976


Industry: Biotechnology

Sector: Healthcare


Windtree Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing novel surfactant therapies for respiratory diseases and other potential applications. Its proprietary technology platform produces a synthetic peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant — and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. The company’s lead product candidate includes AEROSURF, a drug/device product that combines the proprietary KL4 surfactant and aerosolization technologies, which is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants. It is also developing aerosolized KL4 surfactant for various respiratory diseases. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was founded in 1992 and is based in Warrington, Pennsylvania.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE